Direct Rx recalls Lidocaine Ointment USP, 5.0% 50g jars, because it is weaker than it should be
The notice says the Lidocaine Ointment USP, 5.0 % 50g jar is subpotent, meaning the drug is weaker than it should be, and 493 jars were distributed nationwide within the United States.
What to do
The notice does not give instructions. Read the official notice for details.
Note from Recalled Today: Don't stop taking a prescribed medicine before you talk to your pharmacist or doctor.
Recall details
- Product
- Lidocaine Ointment USP, 5.0 % 50g JAR, Rx only, Packaged and Distributed by: Direct Rx Dawsonville, GA 30534, NDC 72189-0211-50
- Company
- Direct Rx
- Hazard
- Subpotent Drug
- Units
- 493 jars
- Where sold
- Nationwide within the United States
- FDA classification
- Class II · Ongoing
- Classified by FDA
- October 29, 2026
- Recall started
- September 29, 2026
- FDA enforcement report
- November 4, 2026
- Identifiers
- Codes: LOT#: 03AP2511, 30AP2518, 18JU2519, 18JU2520, Exp. Date 04/30/2027.
- FDA recall number: D-0107-2027
The headline, summary and steps above are written in plain English from the official notice below. Identifiers are copied exactly as the agency published them. Always check the official notice before you act.
Official notice
The notice's own wording from FDA.
- Product
- Lidocaine Ointment USP, 5.0 % 50g JAR, Rx only, Packaged and Distributed by: Direct Rx Dawsonville, GA 30534, NDC 72189-0211-50
- Reason for recall
- Subpotent Drug
- Classification
- Class II (Ongoing)
- Distribution
- Nationwide within the United States
- Quantity
- 493 jars
Related recalls
Taro recalls Lidocaine Ointment 5% 50 g jars over failed strength test
During 24-month stability testing, the ointment failed the test for how evenly the active ingredient is mixed, so the strength of the medicine in the jars may not be what the label says.
Sun Pharma /Taro · 65,328 50g jars
Preferred Pharmaceuticals recalls Lidocaine Ointment USP, 5% in 50 g jars over failed content uniformity specs
The notice says this lidocaine ointment failed content uniformity specifications, and it was distributed nationwide in the USA.